High Prevalence of Infectious Diseases Drives the Global Antibacterial Drugs Market
Obtain Report Details @ http://www.transparencymarketresearch.com/antibacterial-drugs-market.html
Antibacterial drugs are being in use since the discovery of the first antibacterial in the form of penicillin in 1928, and presently a wide range of antibacterials in several formulations are commercially available and used for the treatment of various indications like pneumonia, tuberculosis, tetanus, diphtheria, diarrhea, legionellosis and other diseases.
The global antibacterial drugs market has been categorized into eight segments based on their class which include: aminoglycosides, β-lactams, tetracyclines, sulfonamides, quinolones/ fluoroquinolones, macrolides, phenicols, and miscellaneous antibacterials. In 2014, β-lactams occupied the leading position with a share of 57.7% of the global antibacterial drugs market followed by the quinolones.
However, these drug classes are expected to witness a decline in their market share during the forecast period due to scheduled patent expiry of key branded formulations, coupled with growing number of drug resistant bacterial strains and increasing influx of generic drugs. Hence, on account of the factors mentioned above, the global antibacterial drugs market is expected to witness slow growth during the forecast period 2015 to 2023. However, the miscellaneous antibacterials segment is expected to grow with the highest CAGR accompanied with growing demand for therapies against bacterial infections and rising geriatric populations are some of the factors that are anticipated to maintain the growth of the antibacterial drugs market.
Additionally, expected commercialization of various antibacterial agents that are currently in developmental stages, such as solithromycin (Cempra, Inc.), VivaGel (SPL7013) (Starpharma Holdings Limited), surotomycin (Merck & Co.) MK-3415A (Merck & Co.) during the forecast period is also expected to profound impact on growth of this market.
Asia-Pacific held the largest share of the revenue generated by the global antibacterial drugs market in 2014. This region is also expected to experience the highest growth rate during the forecast period 2015 to 2023. The major factors responsible for this region to hold leadership in this market in 2014 include presence of large number of generic manufacturers and active pharmaceutical ingredient (API) manufacturers in Asian countries, growing incidences of bacterial infections such as MRSA (methicillin resistant Staphylococcus aureus) and tuberculosis and increasing purchasing power of the domestic population.
For more information on this report, fill the form @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1567
Moreover, developing health care infrastructure, presence of a large population base and growing geriatric population which is more prone to diseases would consequently increase the uptake of antibacterial drugs in Asia. North America held the second largest revenue share followed by Europe in the antibacterial drugs market in 2014. Market maturity, shortened product lifecycle, stringent regulatory requirements and generic infiltration are some of the factors that accounted for slow growth of this market.
AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Allergen plc, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer, Inc., and Sanofi are the major players engaged in the development, production and marketing of various antibacterial drugs. These players have worldwide presence in the pharmaceutical industry and are involved in constant competition with each other. Pfizer, Inc. was observed to be the most promising and leading player in the Antibacterial drugs market. Major customers for their antibacterial drugs include hospitals, private clinics, physicians and patients.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
You can edit or delete your press release High Prevalence of Infectious Diseases Drives the Global Antibacterial Drugs Market here
News-ID: 498513 • Views: 246
More Releases from Transparency Market Research
Water Meter Market Volume Analysis, Segments, Value Share And Key Trends; 2016 - …
TMR’s report offers a complete analysis of the global Water Meter Market with an in-depth analysis of facets such as notable developments, challenges, and key trends. The report also focuses on the drivers propelling the growth of the global Water Meter Market. Browse Our Report @ https://www.transparencymarketresearch.com/water-meter-market.html The global Water Meter Market is expected to show a promising CAGR over the course of the given forecast period. With the development of its
Collaborative Robot Market – Market Data, Industry Analysis, Size, and Share; …
TMR’s report offers a complete analysis of the global Collaborative Robot Market with an in-depth analysis of facets such as notable developments, challenges, and key trends. The report also focuses on the drivers propelling the growth of the global Collaborative Robot Market. Browse Our Report @ https://www.transparencymarketresearch.com/collaborative-robots-market.html The global Collaborative Robot Market is expected to show a promising CAGR over the course of the given forecast period. With the development of its
Computer Numerical Controls (CNC) Market : Segments, Opportunity, Growth And For …
TMR’s report offers a complete analysis of the global Computer Numerical Controls (CNC) Market with an in-depth analysis of facets such as notable developments, challenges, and key trends. The report also focuses on the drivers propelling the growth of the global Computer Numerical Controls (CNC) Market. Browse Our Report @ https://www.transparencymarketresearch.com/computer-numerical-controls.html The global Computer Numerical Controls (CNC) Market is expected to show a promising CAGR over the course of the given forecast
Temperature Sensor Market Global Industry – Key Players, Size, Trends, Opportu …
TMR’s report offers a complete analysis of the global Temperature Sensor Market with an in-depth analysis of facets such as notable developments, challenges, and key trends. The report also focuses on the drivers propelling the growth of the global Temperature Sensor Market. Browse Our Report @ https://www.transparencymarketresearch.com/temperature-sensors-market.html The global Temperature Sensor Market is expected to show a promising CAGR over the course of the given forecast period. With the development of its
More Releases for Antibacterial
Global Antibacterial Drugs Market Research Report
This report studies the global Antibacterial Drugs market status and forecast, categorizes the global Antibacterial Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Bayer AG Pfizer Inc. Sanofi GlaxoSmithKline Plc. (GSK) Merck & Co., Inc. AstraZeneca Johnson and Johnson Bristol
Global Antibacterial Drugs Market: Regional Overview
The global antibacterial drugs market features a fairly competitive landscape and leading players include Allergan, Plc., Novartis AG, Bristol Myers Squibb Company, Johnson and Johnson, AstraZeneca, Merck & Co., Inc., GlaxoSmithKline Plc. (GSK), Sanofi, Pfizer Inc., Bayer AG, notes Transparency Market Research (TMR). Over the years, the competition in the market is expected to intensify. A number of prominent players are focusing on entering into strategic collaborations and mulling
Antibacterial Drugs Market: Regional & Competitive Analysis
The global antibacterial drugs market, according to TMR, could expand at a CAGR of 1.30% between 2015 and 2023 to achieve a revenue valuation of nearly US$38.9 bn by the final forecast year. Although β-lactams had dominated the market in the past with a larger share, the drug class could lose its share to miscellaneous antibacterials, which are projected to rise at a higher growth rate during the forecast period.
Animal Antibacterial Peptide 2024 Market Research Report
Peptides are derived from animal source and possess antibacterial activity that comes under animal antibacterial peptides. They contain residue of amino acids generally about 15 to 45. Antibacterial peptides are the effector molecules of innate immunity. Majority of the antibacterial peptides are cationic in nature. In insects, the cecropin type of linear peptide without cysteine are found. Now, more than 900 sequences of proteins and antibacterial peptides from plants and
Antibacterial Drug Development Market Pipeline Review 2017
Antibacterial Therapies Drug Development Pipeline Review 2017 report covers the drugs used in the prophylaxis and treatment of bacterial infections. With a growing global concern over antimicrobial resistance and its progressive growth, there is a pronounced need for innovation within this market. There are over 1400 products in active development in the antibacterial drug market, with the majority of products being small molecules. Vaccines are also well established within the
Antibacterial Drugs Market - Global Industry Insights 2024
Prevalence of bacterial infections and diseases is especially high in third world countries and significantly hampers quality of life across the globe. Further adding to the woes of the affected population is the increasing strains of bacteria that are resistant to conventional antibacterial drugs. The epidemic of antibacterial resistance has spurred interest among the global healthcare organizations and a few pharmaceutical companies and research institutes to develop next-generation antibacterial